Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder
Clinical trial NCT00061802 · COMPLETED
Trial details
- NCT number
- NCT00061802
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.